Litcius/Paper detail

First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3)

Sachiko Ezoe, Nirianne Palacpac, Kohhei Tetsutani, Kouji Yamamoto, Kiyoshi Okada, Masaki Taira, Sumiyuki Nishida, Haruhiko Hirata, Atsushi Ogata, Tomomi Yamada, Masanori Yagi, Jyotheeswara R. Edula, Yuko Oishi, Takahiro Tougan, Ken J. Ishii, Akira Myoui, Toshihiro Horii

2020Vaccine29 citationsDOI

Topics & Concepts

MedicineMalaria vaccineAdjuvantImmunogenicityVaccinationMalariaImmunologyPlaceboAntibodyInternal medicineClinical trialPlasmodium falciparumGastroenterologyPathologyAlternative medicineMalaria Research and Controlvaccines and immunoinformatics approachesImmunotherapy and Immune Responses
First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3) | Litcius